Topic Hub
7 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 7 of 7 clinical reviews.
A clinician-reviewed deep dive into the emerging biological mechanisms behind male hypogonadism, covering hypothalamic-pituitary signaling, metabolic drivers, epigenetic factors, and what these findings mean for diagnosis and treatment in 2024.
Read clinical reviewA comprehensive review of the socioeconomic burden of male hypogonadism, including direct medical costs, lost productivity, mental health consequences, and the cost-effectiveness of testosterone replacement therapy.
Read clinical reviewA clinician-reviewed overview of male hypogonadism prevalence worldwide, secular trends, risk factors, and what the latest epidemiological data mean for diagnosis and treatment.
Read clinical reviewA physician-reviewed timeline of male hypogonadism treatment from early organotherapy in the 1800s through modern testosterone formulations, GnRH analogs, and emerging peptide therapies, with primary-source citations throughout.
Read clinical reviewA clinician-reviewed deep dive into the unresolved debates around male hypogonadism diagnosis, testosterone thresholds, cardiovascular risk, TRT in older men, and fertility outcomes, with primary-source citations throughout.
Read clinical reviewA clinical deep-dive into how race and ethnicity shape testosterone levels, hypogonadism diagnosis rates, and treatment access in men across the United States, with primary-source citations throughout.
Read clinical reviewA clinical deep-dive into rare and atypical presentations of male hypogonadism, including fertile eunuch syndrome, Kallmann syndrome variants, late-onset hypogonadism without classic symptoms, and medication-induced forms, with primary-source citations and practical diagnostic guidance.
Read clinical review